Growth Metrics

OmniAb (OABI) Operating Expenses (2021 - 2026)

OmniAb (OABI) reported Operating Expenses of $22.3 million for Q1 2026, down 3.23% year-over-year from $23.0 million in Q1 2025, and down 7.81% on a QoQ basis from $24.1 million in Q4 2025.

OmniAb (OABI) has 6 years of Operating Expenses data on file, last reported at $22.3 million in Q1 2026.

  • Quarterly Operating Expenses fell 3.23% year-over-year to $22.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $86.9 million (down 10.91% YoY) and the FY2025 annual result came in at $87.6 million, down 13.14% from the prior year.
  • Operating Expenses eased to $22.3 million in Q1 2026 per OABI's latest filing, from $24.1 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $26.7 million in Q4 2024 and bottomed at $17.8 million in Q1 2022.
  • The 5-year median for Operating Expenses is $23.9 million (2024), against an average of $23.5 million.
  • Peak annual rise in Operating Expenses reached 904476.66% in 2022, while the deepest fall reached 62.53% in 2022.
  • Tracing OABI's Operating Expenses over 5 years: stood at $26.3 million in 2022, then retreated by 1.02% to $26.0 million in 2023, then climbed by 2.52% to $26.7 million in 2024, then fell by 9.53% to $24.1 million in 2025, then dropped by 7.81% to $22.3 million in 2026.
  • Per Business Quant, the three latest OABI Operating Expenses figures stand at $22.3 million (Q1 2026), $24.1 million (Q4 2025), and $20.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.97 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 4.33 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -138.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 15.76 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.85 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.82 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.96 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 898.54 Mn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn 22.26 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 22.26 Mn
Dec 31, 2025 24.14 Mn
Sep 30, 2025 20.38 Mn
Jun 30, 2025 20.12 Mn
Mar 31, 2025 23.00 Mn
Dec 31, 2024 26.68 Mn
Sep 30, 2024 23.94 Mn
Jun 30, 2024 23.92 Mn
Mar 31, 2024 26.35 Mn
Dec 31, 2023 26.03 Mn
Sep 30, 2023 25.79 Mn
Jun 30, 2023 26.39 Mn
Mar 31, 2023 25.37 Mn
Dec 31, 2022 26.30 Mn
Sep 30, 2022 21.82 Mn
Jun 30, 2022 19.77 Mn
Mar 31, 2022 17.85 Mn
Dec 31, 2021 70.18 Mn
Sep 30, 2021 170,579.00
Jun 30, 2021 2,185.00
Mar 31, 2021 7,786.00